Kiniksa Pharmaceuticals International, plc (KNSA) Operating margin 2021–2025
Kiniksa Pharmaceuticals International, plc (KNSA) operating margin by fiscal year — reported operating income divided by reported revenue.
11.4%FY2025 · since FY2021: -406.4% → 11.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 11.4% | +22.2 pp |
| FY2024 | -10.8% | -1.5 pp |
| FY2023 | -9.3% | -13.8 pp |
| FY2022 | 4.4% | +410.8 pp |
| FY2021 | -406.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice